Inhibitors of SARS-CoV‑2 Entry: Current and Future Opportunities

Xiu, Siyu; Dick, Alexej; Ju, Han; Mirzaie, Sako; Abdi, Fatemeh; Cocklin, Simon; Zhan, Peng; Liu, Xinyong

doi:10.1021/acs.jmedchem.0c00502

Public

Inhibitors of SARS-CoV‑2 Entry: Current and Future Opportunities

Published in Journal of Medicinal Chemistry • Jun 15, 2020

Authors:

Siyu Xiu

Alexej Dick

Han Ju

Abstract

Recently, a novel coronavirus initially designated 2019-nCoV but now termed SARS-CoV-2 has emerged and raised global concerns due to its virulence. SARS-CoV-2 is the etiological agent of "coronavirus disease 2019", abbreviated to COVID-19, which despite only being identified at the very end of 2019,...

Subject

Coronavirus

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Pandemic

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!